Global Patent Index - EP 0981603 A1

EP 0981603 A1 2000-03-01 - MODELS FOR HAEMATOPOIESIS

Title (en)

MODELS FOR HAEMATOPOIESIS

Title (de)

HAEMATOPOIESIE-MODELL

Title (fr)

MODELES DE L'HEMATOPOIESE

Publication

EP 0981603 A1 (EN)

Application

EP 98905158 A

Priority

  • AU 9800139 W
  • AU PO540997 A

Abstract (en)

[origin: WO9839413A1] The invention relates to in vitro and in vivo models for haematopoiesis, and to novel haematopoietic factors identified using these models. In a preferred embodiment, the invention relates to a factor which promotes production of neutrophils.

IPC 1-7 (main, further and additional classification)

C12N 5/06; A01K 67/027; A61K 38/19; A61K 39/395; C07K 14/53; C07K 14/535; C07K 16/24; C12N 5/08; C12N 15/19

IPC 8 full level (invention and additional information)

C07K 14/52 (2006.01); C12N 5/0787 (2010.01); C12N 15/85 (2006.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

C12N 15/8509 (2013.01); A01K 67/0276 (2013.01); C07K 14/52 (2013.01); C12N 5/0642 (2013.01); A01K 2217/05 (2013.01); A01K 2217/075 (2013.01); A01K 2227/105 (2013.01); A01K 2267/03 (2013.01); A01K 2267/0381 (2013.01); A61K 38/00 (2013.01); C12N 2500/02 (2013.01); C12N 2502/1394 (2013.01); C12N 2503/00 (2013.01); C12N 2517/02 (2013.01)

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9839413 A1 19980911; AU PO540997 D0 19970327; EP 0981603 A1 20000301; EP 0981603 A4 20030102

INPADOC legal status


2003-04-23 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20021001

2003-01-02 [A4] SUPPLEMENTARY SEARCH REPORT

- Effective date: 20021115

2003-01-02 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A4

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

2000-03-01 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19990928

2000-03-01 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE